Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.

Johnson DB, Reynolds KL, Sullivan RJ, Balko JM, Patrinely JR, Cappelli LC, Naidoo J, Moslehi JJ
Lancet Oncol. 2020 21 (8): e398-e404

PMID: 32758477 · DOI:10.1016/S1470-2045(20)30107-8

MeSH Terms (6)

Antineoplastic Agents, Immunological Humans Medical Oncology Neoplasms Patient Care Patient Education as Topic

Connections (1)

This publication is referenced by other Labnodes entities: